BIIB122
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BIIB122, covering 2024-06-26 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD) [Phase 2]